David Roth For Idaho US Inactive
DAVID ROTH FOR US SENATE
Ad copy
Talk about REAL PEOPLE facing REAL PROBLEMS that need REAL SOLUTIONS. Housing costs are skyrocketing in Idaho. Coupled with the high cost of Insulin many Idahoans are having to face a difficult choice. They either risk their lives by rationing critical medication or they face homelessness. It does not have to be this way. When I get to the Senate I will work with my colleagues to cap the price of Insulin, like they do in just about every other developed nation in the world.
↗ View in Meta Ad Library (the live creative — image/video/layout)
Performance proxies
| Overall score | 19.3/100 |
| Spend / Reach / Long. / Eff. | 0.0 · 24.3 · 1.7 · 51.2 |
| Spend range | <USD 99 |
| Impressions | 100 – 999 |
| CPM (≈ $/1k impr) | USD 90.08 |
| Est. audience size | 10,001 – 50,000 |
| Days live | 7 (2022-03-23 → 2022-03-30) |
| Created | 2022-03-23 |
| Creative variants | 1 body · 0 headline |
| Platforms | |
| Languages | en |
| Candidate | ID — David Roth |
| Surfaced by | “senate:David Roth” |
🧠 AI analysis
| Issue | healthcare |
| Framing | issue advocacy |
| Message type | persuasion |
| Emotional appeal | fear |
| Production tier | semi pro |
| Who pictured | none |
| Symbols | healthcare, money cash |
| Call to action | none |
| Standout element | Stark either/or choice juxtaposing insulin pens against an apartment building on a dark blue background |
| Tactic | The forced-choice framing ('Insulin or Rent?') weaponizes economic anxiety to make an abstract policy issue viscerally personal and urgent. |
Where it ran (delivery by region)
| Idaho | 92.5% |
| Washington | 1.7% |
| Oregon | 1.4% |
| North Carolina | 0.7% |
| Washington, District of Columbia | 0.3% |
| South Carolina | 0.3% |
| New York | 0.3% |
Who saw it (delivery)
| 18-24 · female | 0.3% |
| 18-24 · male | 1.0% |
| 25-34 · unknown | 0.3% |
| 45-54 · male | 4.7% |
| 45-54 · female | 11.5% |
| 65+ · male | 9.2% |
| 55-64 · male | 8.5% |
| 35-44 · female | 11.2% |
| 55-64 · female | 16.3% |
| 65+ · female | 25.4% |
| 35-44 · unknown | 0.3% |
| 25-34 · female | 4.4% |
| 45-54 · unknown | 0.3% |
| 25-34 · male | 2.7% |
| 35-44 · male | 3.1% |
| 65+ · unknown | 0.7% |
